Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI318

Isolation of mycobacterium-reactive CD1-restricted T cells from patients with human immunodeficiency virus infection.

J Gong, S Stenger, J A Zack, B E Jones, G C Bristol, R L Modlin, P J Morrissey, and P F Barnes

Center for Pulmonary and Infectious Disease Control, The University of Texas Health Center, Tyler, Texas 75710, USA.

Find articles by Gong, J. in: PubMed | Google Scholar

Center for Pulmonary and Infectious Disease Control, The University of Texas Health Center, Tyler, Texas 75710, USA.

Find articles by Stenger, S. in: PubMed | Google Scholar

Center for Pulmonary and Infectious Disease Control, The University of Texas Health Center, Tyler, Texas 75710, USA.

Find articles by Zack, J. in: PubMed | Google Scholar

Center for Pulmonary and Infectious Disease Control, The University of Texas Health Center, Tyler, Texas 75710, USA.

Find articles by Jones, B. in: PubMed | Google Scholar

Center for Pulmonary and Infectious Disease Control, The University of Texas Health Center, Tyler, Texas 75710, USA.

Find articles by Bristol, G. in: PubMed | Google Scholar

Center for Pulmonary and Infectious Disease Control, The University of Texas Health Center, Tyler, Texas 75710, USA.

Find articles by Modlin, R. in: PubMed | Google Scholar

Center for Pulmonary and Infectious Disease Control, The University of Texas Health Center, Tyler, Texas 75710, USA.

Find articles by Morrissey, P. in: PubMed | Google Scholar

Center for Pulmonary and Infectious Disease Control, The University of Texas Health Center, Tyler, Texas 75710, USA.

Find articles by Barnes, P. in: PubMed | Google Scholar

Published January 15, 1998 - More info

Published in Volume 101, Issue 2 on January 15, 1998
J Clin Invest. 1998;101(2):383–389. https://doi.org/10.1172/JCI318.
© 1998 The American Society for Clinical Investigation
Published January 15, 1998 - Version history
View PDF
Abstract

Because CD1-restricted T cells lack CD4 but produce IFN-gamma in response to nonpeptide mycobacterial antigens, they could play a unique role in immunity to tuberculosis. We studied CD1-restricted T cells in the context of HIV infection by expanding CD4(-) T cell lines from 10 HIV-infected patients. Upon stimulation with Mycobacterium tuberculosis antigen or upon exposure to macrophages infected with M. tuberculosis, these T cell lines proliferated, produced IFN-gamma, and showed cytolytic T cell (CTL) activity against macrophages pulsed with mycobacterial antigen, findings consistent with a protective role against M. tuberculosis. Anti-CD1b antibodies abrogated T cell proliferation, IFN-gamma production, and CTL activity, demonstrating that these T cells are CD1 restricted. IFN-gamma production in response to M. tuberculosis was enhanced by antitransforming growth factor-beta in 8/10 lines, and by IL-15 in 2/10 lines. IFN-gamma production was augmented in a nonantigen-specific manner by IL-12 in 4/8 lines. When live HIV was cocultured with CD1-restricted T cell lines, p24 antigen and proviral DNA were not detected, indicating that the T cells were not infectable with HIV. Vaccination strategies aimed at activation and expansion of M. tuberculosis-reactive CD1-restricted T cells in HIV-infected patients may constitute a novel means to provide protection against tuberculosis, while minimizing the risk of enhancing HIV replication through stimulation of CD4(+) cells.

Version history
  • Version 1 (January 15, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts